The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Greenwich LifeSciences, Inc(NASDAQ:GLSI)


Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other human epidermal growth factor receptor 2/neu-expressing (HER2/neu) cancers. Its lead product candidate is the GP2, an immunotherapy, which ...
Website: http://www.greenwichlifesciences.com
Founded: 2006
CEO: Snehal Patel
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Greenwich LifeSciences Days Payable Outstanding ttm (DPO)
Greenwich LifeSciences Op Cashflow Per Share ttm
Greenwich LifeSciences Free Cashflow Per Share ttm
Greenwich LifeSciences Cash Per Share ttm
Greenwich LifeSciences (GAAP) P/E ratio ttm
Greenwich LifeSciences P/B ratio ttm
No extra charts and metrics for this ticker.